Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1562902A H5N1 influenza vaccine in children
NCT01379937Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2011
- Primary completion
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Adjupanrix in avian influenza (HPAI), sponsored by GSK. Started Jul 2011; status: completed.
02
Drugs
Adjupanrix
03
Conditions
avian influenza (HPAI)
Beyond the preview
Go deeper on NCT01379937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379937.